Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Emotional Distress on First Line Therapy in Patients With Metastatic Breast Cancer (EIRENE): a Prospective Observational Study

NCT06994377 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT06994377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06994377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Emotional Distress on First Line Therapy in Patients With Metastatic Breast Cancer (EIRENE): a Prospective Observational Study
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
June 25, 2025
Completion date
June 30, 2029
Enrollment
1,000 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer